Table 1 Demographic characteristics, comorbidity, and medication in patient with and without IBD
Variable | IBD | p-value | ||||
|---|---|---|---|---|---|---|
No N = 12,126 |  | Yes N = 12,126 | ||||
N | (%) | Â | N | (%) | ||
Sex |  |  |  |  |  | > 0.999 |
 Female | 5419 | (44.69) |  | 5419 | (44.69) |  |
 Male | 6707 | (55.31) |  | 6707 | (55.31) |  |
Age |  |  |  |  |  | > 0.999 |
 ≤ 49 | 5732 | (47.27) |  | 5732 | (47.27) |  |
 50–64 | 2788 | (22.99) |  | 2788 | (22.99) |  |
 ≥ 65 | 3606 | (29.74) |  | 3606 | (29.74) |  |
 mean (SD)a | 49.19 | (23.96) |  | 49.18 | (23.94) | 0.966 |
Comorbidity | Â | Â | Â | Â | Â | Â |
 Hyperlipidemia | 1420 | (11.71) |  | 3130 | (25.81) | < 0.001 |
 Obesity | 45 | (0.37) |  | 90 | (0.74) | < 0.001 |
 Coronary artery disease (CAD) | 537 | (4.43) |  | 2053 | (16.93) | < 0.001 |
 Hypertension | 1805 | (14.89) |  | 4494 | (37.06) | < 0.001 |
 Chronic kidney disease (CKD) | 125 | (1.03) |  | 991 | (8.17) | < 0.001 |
Medication | Â | Â | Â | Â | Â | Â |
 Corticosteroids |  |  |  | 10,454 | (86.21) |  |
 Immunomodulators |  |  |  | 1862 | (15.36) |  |
 Aminosalicylates |  |  |  | 5845 | (48.20) |  |
 Biologics and small molecule |  |  |  | 1009 | (8.32) |  |
Surgical treatment | Â | Â | Â | 2286 | (18.85) | Â |
Follow-up time, years | Â | Â | Â | Â | Â | Â |
 mean (SD)a | 5.94 | (2.95) |  | 5.28 | (3.17) | < 0.001 |